FDA Clearance Tracker · P000025-S014
MED-EL COMBI 40+ COCHLEAR IMPLANT SYSTEM PULSARCI100 COCHLEAR IMPLANT
Last checked: Nov 20, 2026Latest source record: Nov 17, 2004 (this decision)Source: openFDAMethods & limitations
Decided
Nov 17, 2004
Approved
Time to decision
254 days
Received Mar 8, 2004. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P000025-S014
- Device name
- MED-EL COMBI 40+ COCHLEAR IMPLANT SYSTEM PULSARCI100 COCHLEAR IMPLANT
- Applicant
- Med-El Corp.
- Applicant location
- Innsbruck
- Received
- Mar 8, 2004
- Decided
- Nov 17, 2004
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P000025
Device type
- Device type
- Implant, cochlear (MCM)
- Device class
- Class III
- Specialty
- Otolaryngology (ENT)
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE PULSARCI100 COCHLEAR IMPLANT, A MEMBER OF COMBI C40+ COCHLEAR IMPLANT SYSTEM.
Source documents
Other decisions for Med-El Corp.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- MED-EL CI SystemPMA supplement
P000025-S134 · Decided Nov 26, 2025 · 287 days after receipt · Panel Track
Device type: Implant, cochlear (MCM) · Otolaryngology (ENT)
3 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.